There are global coagulation tests and hemostatic molecular markers in
the diagnosis of disseminated intravascular coagulation(DIC). In the global
coagulation tests, the sensitivity of prothrombin time ratio and fibrinogen
for the diagnosis of DIC is low, but their specificity is high. In platelet
count and FDP, the sensitivity for the diagnosis of DIC is good, but the
specificity is low. Fibrinogen may be unsuitable for the diagnosis of DIC,
because it increases of the inflammatory reaction. It is possible to theoretically
diagnose DIC by increased tissue factor production. It is currently considered
that hemostatic molecular marker should be utilized to diagnose DIC. Thrombin-antithrombin
complex and soluble fibrin are reflected to hypercoagulable state, thrombomodulin
to vascular endothelial cell injuries, and plasminogen activator inhibitor-I
to hypofibrinolytic state. In leukemia with DIC, hyperfibrinolysis and
marked bleeding symptoms are often observed. In septicemia with DIC, hypofibrinolysis
and severe organ failure often occur. Early diagnosis and treatment of
DIC are important to improve the prognosis, and hemostatic molecular markers
should be useful for that purpose.
[Rinsho Byori 50 : 768`772, 2002]
*Department of Laboratory Medicine, Mie University School of Medicine, Tsu 514-8507
yKey WordszDIC(dν«ΗΰΓΕΗ)Chemostatic molecular marker(~nͺq}[J[)Cglobal coagulation tests(O[o~n}[J[)Cpre-DIC(ϊDIC)Coutcome(\γ)
*OdεγwΥ°Έγw(§514-8507 Γs]Λ΄2-174)
E-mail :wadahide@clin.medic.mei-u.ac.jp